Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Targeting Mrna-Coding Genes in Prostate Cancer Using Crispr/Cas9 Technology With a Special Focus on Androgen Receptor Signaling Publisher Pubmed



Tabibian M3 ; Moghaddam FS1 ; Motevaseli E2 ; Ghafourifard S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Cellular and Molecular Biology, Faculty of Life Sciences and Biotechnologies, Shahid Beheshti University, Tehran, Iran

Source: Cell Communication and Signaling Published:2024


Abstract

Background: Prostate cancer is among prevalent cancers in men. Numerous strategies have been proposed to intervene with the important prostate cancer-related signaling pathways. Among the most promising strategies is CRISPR/Cas9 strategy. This strategy has been used to modify expression of a number of genes in prostate cancer cells. Aims: This review summarizes the most recent progresses in the application of CRISPR/Cas9 strategy in modification of prostate cancer-related phenotypes with an especial focus on pathways related to androgen receptor signaling. Conclusion: CRISPR/Cas9 technology has successfully targeted several genes in the prostate cancer cells. Moreover, the efficiency of this technique in reducing tumor burden has been tested in animal models of prostate cancer. Most of targeted genes have been related with the androgen receptor signaling. Targeted modulation of these genes have affected growth of castration-resistant prostate cancer. PI3K/AKT/mTOR signaling and immune response-related genes have been other targets that have been successfully modulated by CRISPR/Cas9 technology in prostate cancer. Based on the rapid translation of this technology into the clinical application, it is anticipated that novel treatments based on this technique change the outcome of this malignancy in future. © The Author(s) 2024.
Related Docs
View other Related Docs
1. Crispr-Cas9 in Basic and Translational Aspects of Cancer Therapy, BioImpacts (2024)
2. Implications of Crispr-Cas9 Genome Editing Methods in Atherosclerotic Cardiovascular Diseases, Current Problems in Cardiology (2023)
3. Technology Developments in Biological Tools for Targeted Genome Surgery, Biotechnology Letters (2015)
4. Nanoparticles-Mediated Crispr/Cas9 Delivery: Recent Advances in Cancer Treatment, Journal of Drug Delivery Science and Technology (2020)
5. Exploring Non-Viral Methods for the Delivery of Crispr-Cas Ribonucleoprotein to Hematopoietic Stem Cells, Stem Cell Research and Therapy (2024)
6. The Crispr Growth Spurt: From Bench to Clinic on Versatile Small Rnas, Journal of Microbiology and Biotechnology (2017)
7. Crispr Pioneers Win 2020 Nobel Prize for Chemistry, Iranian Journal of Public Health (2020)
8. Clinical Applications of the Crispr/Cas9 Genome-Editing System: Delivery Options and Challenges in Precision Medicine, Genes and Diseases (2024)
Experts (# of related papers)
View all Related Experts
Fatemeh Radmanesh (3)
Mohammad Hossein Modarressi (2)
Other Related Docs
9. The Conspicuity of Crispr-Cpf1 System As a Significant Breakthrough in Genome Editing, Current Microbiology (2018)
10. Could Artificial Intelligence Revolutionize the Development of Nanovectors for Gene Therapy and Mrna Vaccines?, Nano Today (2022)
11. Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review, Pharmacological Reviews (2023)
12. Crispr-Interceded Cho Cell Line Development Approaches, Biotechnology and Bioengineering (2023)
13. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools, ACS Pharmacology and Translational Science (2023)
14. Advancing Mesenchymal Stem Cell Therapy With Crispr/Cas9 for Clinical Trial Studies, Advances in Experimental Medicine and Biology (2020)
15. Crispr/Cas System: A Powerful Strategy to Improve Monogenic Human Diseases As Therapeutic Delivery; Current Applications and Challenges, Current Gene Therapy (2025)
16. Saponin and Fluorine-Modified Polycation As a Versatile Gene Delivery System, Nanotechnology (2022)
17. Nanotechnological Approaches in Prostate Cancer Therapy: Integration of Engineering and Biology, Nano Today (2022)
18. Combination of Genetics and Nanotechnology for Down Syndrome Modification: A Potential Hypothesis and Review of the Literature, Iranian Journal of Public Health (2019)
19. Smart Strategies for Precise Delivery of Crispr/Cas9 in Genome Editing, ACS Applied Bio Materials (2022)
20. Recent Advances in Targeting Mtor Signaling Pathway Using Small Molecule Inhibitors, Journal of Drug Targeting (2017)
21. Synthesis and Characterization of Vitamin D3-Functionalized Carbon Dots for Crispr/Cas9 Delivery, Nanomedicine (2021)
22. Vector and Cell Line Engineering Technologies Toward Recombinant Protein Expression in Mammalian Cell Lines, Applied Biochemistry and Biotechnology (2018)
23. The Significance of Bioengineered Nanoplatforms Against Sars-Cov-2: From Detection to Genome Editing, Life Sciences (2021)
24. Statins Block Mammalian Target of Rapamycin Pathway: A Possible Novel Therapeutic Strategy for Inflammatory, Malignant and Neurodegenerative Diseases, Inflammopharmacology (2023)
25. Smart Arginine-Equipped Polycationic Nanoparticles for P/Crispr Delivery Into Cells, Nanotechnology (2022)
26. Crispr-Cas9-Mediated Gene Therapy in Lung Cancer, Clinical and Translational Oncology (2023)
27. The Horizon of Gene Therapy in Modern Medicine: Advances and Challenges, Advances in Experimental Medicine and Biology (2020)
28. Polyethylenimine-Functionalized Carbon Dots for Delivery of Crispr/Cas9 Complexes, ACS Applied Bio Materials (2021)
29. Genetic Disruption of the Klf1 Gene to Overexpress the Γ-Globin Gene Using the Crispr/Cas9 System, Journal of Gene Medicine (2016)
30. Targeting Mammalian Target of Rapamycin: Prospects for the Treatment of Inflammatory Bowel Diseases, Current Medicinal Chemistry (2021)
31. Dyskeratosis Congenita Future: Hematopoietic Stem Cell Transplantation or Gene Therapy?, Gene Reports (2025)